- Home
- » Tags
- » H3 receptor antagonist
Top View
- Download Formulary
- Role of H3-Receptor-Mediated Signaling in Anxiety and Cognition in Wild-Type and Apoe–/– Mice
- The Histamine H3 Receptor: Structure, Pharmacology, and Function
- Wakix, INN-Pitolisant Hydrochloride
- Pharmacokinetics of Neostigmine and Pyridostigmine in Man
- Histaminergic System in Brain Disorders
- Medicaid Health Plan Common Formulary
- And Triple-Acting Agents for Treating Core and Co-Morbid Symptoms of Major Depression: Novel Concepts, New Drugs
- Tommuniciun Clou Un Tai Tai Man United
- Wakix (Pitolisant)
- Central Histaminergic Signaling, Neural Excitability and Epilepsy
- Histamine H3 Receptor Antagonists/Inverse Agonists
- The Role of Histaminergic H1 and H3 Receptors in Food Intake: a Mechanism for Atypical Antipsychotic-Induced Weight Gain?
- Pharmacology of the Ovine Uterine Artery and Umbilical Blood Vessels: Serotonergic and Α- Adrenergic Mechanisms Xiangqun Hu Iowa State University
- The Role of Histamine H3 Receptor Antagonists In
- Histamine H2- and H3-Receptor Antagonists: Synthesis and Characterization of Radio- Labelledand Fluorescent Pharmacological Tool
- Therapeutic Class Review
- Full List by Category
- The Dual-Active Histamine H3 Receptor Antagonist and Acetylcholine Esterase Inhibitor E100 Alleviates Autistic-Like Behaviors An
- The Dual-Active Histamine H3 Receptor Antagonist and Acetylcholine Esterase Inhibitor E100 Alleviates Autistic-Like Behaviors An
- Receptor Improves Wakefulness in Narcolepsy: Studies in Orexin-/- Mice and Patients
- CP.PMN.221 Pitolisant (Wakix)
- Neurological Disease
- Wakix (Pitolisant) Annual Review Date: 09/17/2020
- Author Index
- Discovery of Potential, Dual-Active Histamine H3 Receptor Ligands with Combined Antioxidant Properties
- Pharmacogenomic Biomarkers and Their Applications in Psychiatry
- Applications of Transition Metal Catalysis in Drug Discovery and Development Applications of Transition Metal Catalysis in Drug Discovery and Development
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Mrx CLINICAL ALERT
- Histamine Pharmacology and New CNS Drug Targets Ekaterini Tiligada,1 Konstantinos Kyriakidis,1 Paul L
- Molecular Analysis of the Interaction of the Four Histamine Receptor Subtypes with Antidepressant and Antipsychotic Drugs
- Chapter 14: Histamine (PDF)
- 2019 532.Pdf (908.6Kb)
- Acetylcholine, Histamine, and Cognition: Two Sides of the Same Coin
- Areas of Study
- New Antihistamines – Perspectives in the Treatment of Some Allergic and Inflammatory Disorders
- Long-Term Use of Pitolisant to Treat Patients With
- Tommunom U Tokumenti Uniti
- IOM-Report-Breast-Cancer-And-The
- G.P. Ellis (8).Pdf
- The Roles of Histamine and Its Receptor Ligands in Central Nervous System Disorders: an Update
- PITOLISANT Tablets (Wakix® )
- Shared Care Guideline
- A Novel Potent and Selective Histamine H3 Receptor Antagonist Enerisant: in Vitro